Covalon Technologies Ltd. is a researcher, developer, manufacturer, and marketer of patent-protected medical products that improve patient outcomes and save lives in the areas of infection prevention, advanced wound care, and surgical procedures.
The proprietary CovalGuard™ technology platform leverages Covalon’s 20 years of experience in the development of infection prevention technology which is effective in destroying harmful bacteria to provide antiseptic cleansing.
Covalon’s products are sold through its sales force in the United States into over 2,000 hospitals and through independent distributors to various health care providers around the world, such as hospitals, wound care centers, burn centers, extended/alternate care facilities, acute care facilities, home health care agencies, and physicians’ offices. We also license our technologies and products to large medical companies as well as work with niche start-ups to create novel technology to advance their product offerings in various medical markets.
Covalon has worked with many medical companies including leaders in vascular access devices, I.V. infusion, orthopedics, medical device and patient care distributors, wound care product companies, specialty medical device manufacturers and major contract manufacturers.
Click here to learn more about Covalon.